Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
21 pending office actions • 11 art units • 19 examiners • 0 of 21 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days
The University of Miami maintains a portfolio in the Biotechnology & Pharmaceuticals technology area with 21 pending office actions. This workload is distributed across 11 distinct art units, indicating a diverse range of research and development efforts within the life sciences sector. The presence of 19 distinct examiners suggests that the university's prosecution strategy involves navigating a wide variety of individual examiner preferences and standards. This diversity in examiners and art units requires a versatile approach to patent advocacy to ensure consistency across different technological sub-sectors.
JANG, CHRISTIAN Y is identified as the busiest examiner for this portfolio, currently handling 2 pending office actions. This concentration is relatively low compared to the total volume of 21 pending actions, which implies that the university's patent applications are not heavily clustered under a single official. Practitioners should prepare for a broad examination landscape given the high ratio of 19 distinct examiners to the total pending actions. The distribution across 11 distinct art units further underscores the need for specialized technical expertise when responding to these varied office actions.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (29%) |
| §103 only | 2 (10%) |
| Double-patenting only | 1 (5%) |
| Double-patenting + other | 2 (10%) |
| Multi-statute (no §101) | 9 (43%) |
| No statute on record | 1 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANG, CHRISTIAN Y | 2 | 68.5% | +21.0% |
| HOLTZMAN, KATHERINE ANN | 2 | 65.7% | +58.3% |
| DUONG, JOHNNYKHOI BAO | 1 | 64.5% | +31.6% |
| PRAGANI, RAJAN | 1 | 53.3% | +70.0% |
| HASAN, MOHAMMED A | 1 | 90.3% | +5.1% |
| POHNERT, STEVEN C | 1 | 12.4% | +18.5% |
| KALIHER, HANS CHRISTIAN | 1 | 62.9% | +27.3% |
| LEE, ANDREW P | 1 | 48.3% | +23.1% |
| LUAN, SCOTT | 1 | 65.2% | +12.7% |
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 30d overdue |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 19d overdue |
| 17639510 | QUANTIFICATION OF SYMMETRY AND REPEATABILITY IN LIMB MOTION FOR TREATMENT OF ABNORMAL MOTION PATTERNS | LOPEZ, SEVERO ANTON P | 9d overdue |
| 17759139 | VACCINATION AGAINST ANTIGENS INDUCED IN PATHOGEN-INFECTED CELLS | PUTTLITZ, KARL J | 9d |
| 17915971 | PHOTODYNAMIC ANTIMICROBIAL THERAPY DEVICE | SCHMITT, BENJAMIN ALLYN | 27d |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | GRASER, JENNIFER E | 72d |
| 18867355 | METHOD AND SYSTEM TO MEASURE OBJECTIVE VISUAL PHOTOSENSITIVITY DISCOMFORT THRESHOLD | DUONG, JOHNNYKHOI BAO | — |
| 18745908 | Method and System of Augmenting Cancer Therapy | POHNERT, STEVEN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 30d overdue |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 19d overdue |
| 18672929 | METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS | LEE, ANDREW P | 39d |
| 18867355 | METHOD AND SYSTEM TO MEASURE OBJECTIVE VISUAL PHOTOSENSITIVITY DISCOMFORT THRESHOLD | DUONG, JOHNNYKHOI BAO | — |
| 18861068 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | PRAGANI, RAJAN | — |
| 18745908 | Method and System of Augmenting Cancer Therapy | POHNERT, STEVEN C | — |
| 18713960 | OCULAR DRUG TRANSFER AND DISPENSING DEVICE | KALIHER, HANS CHRISTIAN | — |
| 18666176 | METHOD AND SYSTEM FOR ADJUSTING AUDIO SIGNALS BASED ON MOTION DEVIATION | JANG, CHRISTIAN Y | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 1646 | 3 |
| 3781 | 1 |
| 1691 | 1 |
| 3792 | 1 |
| 1633 | 1 |
| 1634 | 1 |
| 1675 | 1 |
| 3796 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867355 | METHOD AND SYSTEM TO MEASURE OBJECTIVE VISUAL PHOTOSENSITIVITY DISCOMFORT THRESHOLD | DUONG, JOHNNYKHOI BAO | — | §103§112 | Non-Final OA | — | Pending | Nov 19, 2024 |
| 18861068 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | PRAGANI, RAJAN | — | §103 | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18924936 | VISION TESTING VIA PREDICTION-BASED SETTING OF INITIAL STIMULI CHARACTERISTICS FOR USER INTERFACE LOCATIONS | HASAN, MOHAMMED A | — | Other | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18745908 | Method and System of Augmenting Cancer Therapy | POHNERT, STEVEN C | — | §101§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18713960 | OCULAR DRUG TRANSFER AND DISPENSING DEVICE | KALIHER, HANS CHRISTIAN | 3781 | §102§103 | Non-Final OA | — | Pending | May 28, 2024 |
| 18672929 | METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS | LEE, ANDREW P | 1691 | §103 | Final Rejection | 39d | Pending | May 23, 2024 |
| 18666176 | METHOD AND SYSTEM FOR ADJUSTING AUDIO SIGNALS BASED ON MOTION DEVIATION | JANG, CHRISTIAN Y | — | §101DP | Non-Final OA | — | Pending | May 16, 2024 |
| 18655182 | Contact Lens System and Method for Assessing Intraocular Pressure | JANG, CHRISTIAN Y | 3791 | §101§102§103§112Other | Non-Final OA | — | Pending | May 03, 2024 |
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 3792 | §102§103 | Final Rejection | 30d overdue | Pending | Apr 05, 2024 |
| 18418736 | METHOD FOR MANAGING PAIN | SPENCE, JENNIFER SUZANNE | 1633 | §102§103 | Final Rejection | — | Pending | Jan 22, 2024 |
| 18516247 | ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES | HASAN, KHALEDA B | — | DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18556593 | ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES | RIGA, MICHAEL ANGELO | 1634 | §103§112DPOther | Non-Final OA | 69d | Pending | Oct 20, 2023 |
| 18464174 | INFLAMMASOME ANTIBODY COMPOSITON AND METHOD FOR TREATING NEUROLOGIC DISORDER | FONTAINHAS, AURORA M | 1675 | §112DP | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 1646 | §101§103§112Other | Final Rejection | 19d overdue | Pending | Apr 25, 2023 |
| 17995548 | A SYSTEM FOR ASSESSING HUMAN MOVEMENT AND BALANCE | HEALY, NOAH MICHAEL | 3791 | §101§112 | Final Rejection | — | Pending | Oct 05, 2022 |
| 17915971 | PHOTODYNAMIC ANTIMICROBIAL THERAPY DEVICE | SCHMITT, BENJAMIN ALLYN | 3796 | §103§112 | Final Rejection | 27d | Pending | Sep 29, 2022 |
| 17822333 | INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE | SCHWECHTER, BRANDON ROSS | 1674 | §102§103§112 | Non-Final OA | — | Pending | Aug 25, 2022 |
| 17759139 | VACCINATION AGAINST ANTIGENS INDUCED IN PATHOGEN-INFECTED CELLS | PUTTLITZ, KARL J | 1646 | §103§112 | Non-Final OA | 9d | Pending | Jul 20, 2022 |
| 17812058 | METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS | HOLTZMAN, KATHERINE ANN | 1646 | §103§112Other | Non-Final OA | — | Pending | Jul 12, 2022 |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | GRASER, JENNIFER E | 1645 | §103§112 | Final Rejection | 72d | Pending | Jun 15, 2022 |
| 17639510 | QUANTIFICATION OF SYMMETRY AND REPEATABILITY IN LIMB MOTION FOR TREATMENT OF ABNORMAL MOTION PATTERNS | LOPEZ, SEVERO ANTON P | 3791 | §101§103 | Non-Final OA | 9d overdue | Pending | Mar 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial